Claudia Ose

2.4k total citations
44 papers, 1.1k citations indexed

About

Claudia Ose is a scholar working on Psychiatry and Mental health, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Claudia Ose has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 13 papers in Surgery and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Claudia Ose's work include Attention Deficit Hyperactivity Disorder (12 papers), Venous Thromboembolism Diagnosis and Management (7 papers) and Diagnosis and Treatment of Venous Diseases (5 papers). Claudia Ose is often cited by papers focused on Attention Deficit Hyperactivity Disorder (12 papers), Venous Thromboembolism Diagnosis and Management (7 papers) and Diagnosis and Treatment of Venous Diseases (5 papers). Claudia Ose collaborates with scholars based in Germany, Austria and United States. Claudia Ose's co-authors include Roland Fischer, Michael Rösler, Wolfgang Retz, Richard Ammer, Christian Waydhas, D. Nast‐Kolb, Knut Kröger, Barbara Alm, Calvin H. Hirsch and M. E. Scheulen and has published in prestigious journals such as Blood, Scientific Reports and The Lancet Neurology.

In The Last Decade

Claudia Ose

39 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudia Ose Germany 18 446 239 213 194 188 44 1.1k
Victor Urrutia United States 21 111 0.2× 122 0.5× 157 0.7× 48 0.2× 571 3.0× 80 1.6k
A.A. Rabinstein United States 14 128 0.3× 106 0.4× 203 1.0× 96 0.5× 280 1.5× 47 1.6k
Mark A. Rockoff United States 22 480 1.1× 407 1.7× 40 0.2× 70 0.4× 253 1.3× 66 1.8k
D R Holdright United Kingdom 18 364 0.8× 303 1.3× 48 0.2× 193 1.0× 50 0.3× 38 1.4k
Joseph Harbison Ireland 18 122 0.3× 137 0.6× 148 0.7× 78 0.4× 411 2.2× 87 1.5k
Elizabeth A. Noser United States 18 172 0.4× 62 0.3× 197 0.9× 71 0.4× 370 2.0× 28 1.4k
S. Hogue United States 19 147 0.3× 232 1.0× 127 0.6× 38 0.2× 106 0.6× 54 1.1k
Satu Mustanoja Finland 25 222 0.5× 81 0.3× 457 2.1× 185 1.0× 433 2.3× 61 2.4k
J. Andrew McClure Canada 19 320 0.7× 248 1.0× 15 0.1× 111 0.6× 132 0.7× 57 1.2k
Laura Lennihan United States 20 209 0.5× 228 1.0× 47 0.2× 57 0.3× 404 2.1× 29 2.2k

Countries citing papers authored by Claudia Ose

Since Specialization
Citations

This map shows the geographic impact of Claudia Ose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Ose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Ose more than expected).

Fields of papers citing papers by Claudia Ose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Ose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Ose. The network helps show where Claudia Ose may publish in the future.

Co-authorship network of co-authors of Claudia Ose

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Ose. A scholar is included among the top collaborators of Claudia Ose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Ose. Claudia Ose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuske, Silke, et al.. (2024). Emotional and psychological safety in the context of digital transformation in healthcare: a mixed-method strategic foresight study. BMJ Health & Care Informatics. 31(1). e101048–e101048.
3.
Kizina, Kathrin, Benjamin Stolte, Andreas Totzeck, et al.. (2020). Fatigue in adults with spinal muscular atrophy under treatment with nusinersen. Scientific Reports. 10(1). 11069–11069. 26 indexed citations
4.
Obermann, Mark, Claudia Ose, André Scherag, et al.. (2020). Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial. The Lancet Neurology. 20(1). 29–37. 46 indexed citations
7.
Scherag, André, Reinhard W. Holl, Rolf Holle, et al.. (2017). A Structured, Manual-Based Low-Level Intervention vs. Treatment as Usual Evaluated in a Randomized Controlled Trial for Adolescents with Extreme Obesity - the STEREO Trial. Obesity Facts. 10(4). 341–352. 5 indexed citations
9.
Sobanski, Esther, Manfred Döpfner, Claudia Ose, & Roland Fischer. (2013). A non-interventional study of extended-release methylphenidate in the routine treatment of adolescents with ADHD: effectiveness, safety and adherence to treatment. ADHD Attention Deficit and Hyperactivity Disorders. 5(4). 387–395. 4 indexed citations
10.
Sobanski, Esther, Wolfgang Retz, R. Fischer, et al.. (2013). Treatment adherence and persistence in adult ADHD: Results from a twenty-four week controlled clinical trial with extended release methylphenidate. European Psychiatry. 29(5). 324–330. 24 indexed citations
13.
Minor, Thomas, Carolin Pütter, Anja Gallinat, et al.. (2011). Oxygen persufflation as adjunct in liver preservation (OPAL): Study protocol for a randomized controlled trial. Trials. 12(1). 234–234. 19 indexed citations
14.
Rösler, Michael, Wolfgang Retz, Roland Fischer, et al.. (2010). Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD. The World Journal of Biological Psychiatry. 11(5). 709–718. 95 indexed citations
15.
Rösler, Michael, et al.. (2009). A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder. European Archives of Psychiatry and Clinical Neuroscience. 259(6). 368–368. 5 indexed citations
16.
Kröger, Knut, Claudia Ose, Niklas Neumann, et al.. (2005). Risk factors for venous thromboembolic events in cancer patients. Annals of Oncology. 17(2). 297–303. 159 indexed citations
17.
Voggenreiter, G., M. Aufmkolk, Markus Baacke, et al.. (2005). Prone Positioning Improves Oxygenation in Post-Traumatic Lung Injury—A Prospective Randomized Trial. The Journal of Trauma: Injury, Infection, and Critical Care. 59(2). 333–343. 100 indexed citations
18.
Gerber, W.D., Tobias Banaschewski, Dieter Breuer, et al.. (2004). Comparative efficacy of once?a?day extended?release methylphenidate, two?times?daily immediate?release methylphenidate, and placebo in a laboratory school setting. European Child & Adolescent Psychiatry. 13(S1). I93–101. 45 indexed citations
19.
Ruchholtz, Steffen, Christian Waydhas, Claudia Ose, Ulrike Lewan, & D. Nast‐Kolb. (2002). Prehospital Intubation in Severe Thoracic Trauma without Respiratory Insufficiency: A Matched-Pair Analysis Based on the Trauma Registry of the German Trauma Society. The Journal of Trauma: Injury, Infection, and Critical Care. 52(5). 879–886. 51 indexed citations
20.
Heilmann, L., et al.. (1993). Veränderungen der zentralen Hämodynamik und der peripheren Zirkulation in der Schwangerschaft. Geburtshilfe und Frauenheilkunde. 53(7). 472–478. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026